Donate Now
  • What We've Learned
Will using your arthritis medications during pregnancy cause you or your baby to have more infections?
Everyday-Living-7.0-1
Scientific Study Title:
Perinatal Use of Immunosuppressant Therapies and Risk of Infections in Mothers and Babies
Research Category
Tags

Why did we do this research?

Research shows that certain arthritis treatments namely, biologics, can weaken the immune system, putting people at risk of having infections that can be mild (for example, catching a cold) or serious (for example, pneumonia). Some of these treatments are used by women during their pregnancies; however, it is not clear what impact these treatments have on mothers’ or their baby’s immune system. The goal of this research project was to find out whether using biologics during pregnancy causes moms and babies to have more infections, so that prevention and monitoring can take place to ensure that both moms and babies can be healthy. We specifically wanted to explore what happens in mothers during the postpartum period, and what happens in babies during the first year of their life.

What did we do?

Using administrative health data with approved access from the Ministry of Health and the University of British Columbia Research Ethics Board, we investigated…

How often infections occur in moms around the time of delivery, and in babies during the first year after they are born.

Whether the use of biologics is associated with infections and/or whether there are other factors that play a role.

What did we find?

The results of this study found that using biologics during pregnancy was not associated with an increased risk of serious infections in mothers after delivery or in babies during their first year of life.

What are the next steps?

Dr. Mary De Vera is currently working on the Following Maternal, Neonatal, and Childhood Outcomes Associated with Use of Arthritis Medications Perinatally (FAMILY) study, which will build upon this body of research. We expect that the FAMILY study will have more participants and longer follow-up periods, thus providing us with more data on this subject.

The main takeaway from this research is that using biologics during pregnancy is safe and doesn’t appear to significantly increase the risk of serious infections for mothers and their babies.

The Research Team

Principal Investigator

  • Mary De Vera, MSc, PhD, Senior Scientist, Pharmacoepidemiology, Associate Director of Training, Arthritis Research Canada (University of British Columbia)

Co-Investigators

  • Gillian Hanley, PhD, Assistant Professor, Department of Obstetrics and Gynaecology, (University of British Columbia), Vancouver, Canada
  • Larry Lynd, PhD, BSP, Professor Faculty of Pharmaceutical Sciences, (University of British Columbia), Vancouver, Canada
  • Eric Sayre, PhD, Statistician, Arthritis Research Canada
  • Richmond, British Columbia, Canada
  • Nicole Tsao, BSc, MP, PhD candidate, Research Trainee, Arthritis Research Canada; PhD Student, Faculty of Pharmaceutical Sciences, (University of British Columbia), Vancouver, Canada
  • Mohsen Sadatsafavi, MD, PhD, Associate Professor, Faculty of Pharmaceutical Sciences, (University of British Columbia), Vancouver, British Columbia, Canada

Who Funded This Research?

Canadian Institutes of Health Research

How Can People Get Involved?

This study included women with autoimmune diseases who were either taking biologics during pregnancy or not taking them, and it looked at the impact of these treatments on both the mothers and their infants.

More specifically:

  • The participants were women who had at least one autoimmune disease.
  • The study focused on women who had pregnancies between 2002 and 2012.

The women were divided into two groups:

  • Those who took biologics during their pregnancy.
  • Those who did not take biologics during their pregnancy.
  • The infants born to these women were also part of the study. Infants born to women taking biologics during pregnancy were considered to be exposed to biologics, while infants born to women who did not take biologics during pregnancy were considered unexposed.

Media and Infographics

Related Research

What We're Working On Right Now

Exploring a New Immune Cell Therapy for People with Autoimmune Diseases

Systemic sclerosis and systemic lupus erythematosus are serious autoimmune diseases that can cause damage to many organs including the skin, lungs and kidneys. In this project, we will study a new type of treatment that may better control these diseases by targeting the immune cells that cause them. If successful, it could reduce inflammation, slow or stop disease progression, and may even help reset the immune system, so that some patients no longer need long-term immune-suppressing medications.
Read More

Understanding how scleroderma affects people over time

People living with scleroderma experience challenges such as pain, disability, and mental health concerns, but we still don’t know much about how these problems change over time or why some people do better than others. For this research project, our goal is to improve our understanding of how scleroderma affects people’s daily lives and identify factors that may predict changes in their health.
Read More

How can we help Canadians age at home to improve health outcomes and support a sustainable healthcare system?

As Canada’s population ages, home care is important for helping older adults remain safely within their homes. Our research team is linking data from the Canadian Longitudinal Study on Aging with health records in British Columbia, Ontario, and New Brunswick, to track patterns of paid and unpaid home care use over time.
Read More